
NewAmsterdam Pharma Co NV
NAMSHealthcare|Biotechnology|Netherlands
$35.30
-0.66 (-1.84%)
Tangible Book
$5.70
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (45)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer | 2026-06-22 | SELL | 40,000 | $30.2 | $1208K |
| Kooij Louise Frederika | Chief Accounting Officer | 2026-05-26 | SELL | 65,000 | $35.69 | $2319.9K |
| LANGE LOUIS G | Director | 2026-03-11 | SELL | 44,619 | $30.42 | $1357.3K |
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2026-03-09 | SELL | 300,000 | $30.3 | $9090K |
| LANGE LOUIS G | Director | 2026-03-06 | SELL | 28,186 | $29.41 | $829K |
| Davidson Michael H. | CEO | 2026-03-02 | SELL | 443,707 | $33.25 | $14753.3K |
| Davidson Michael H. | CEO | 2026-02-26 | SELL | 306,293 | $34.53 | $10576.3K |
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2026-02-20 | SELL | 45,481 | $35.31 | $1605.9K |
| Kooij Louise Frederika | Chief Accounting Officer | 2026-01-28 | SELL | 72,428 | $32.25 | $2335.8K |
| Kooij Louise Frederika | Chief Accounting Officer | 2026-01-26 | SELL | 72,572 | $33.29 | $2415.9K |
| Somaiya Mayur Ian | CFO | 2026-01-21 | SELL | 100,000 | $32.61 | $3261K |
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2026-01-05 | SELL | 6,000 | $33.25 | $199.5K |
| Kooij Louise Frederika | Chief Accounting Officer | 2026-01-05 | SELL | 2,647 | $33.25 | $88K |
| Somaiya Mayur Ian | CFO | 2026-01-05 | SELL | 5,118 | $33.25 | $170.2K |
| Kooij Louise Frederika | Chief Accounting Officer | 2025-12-26 | SELL | 145,000 | $35.84 | $5196.8K |
| Topper James N | Director | 2025-09-15 | BUY | 660 | $23.7 | $15.6K |
| Kooij Louise Frederika | Chief Accounting Officer | 2025-09-09 | SELL | 150,000 | $25.83 | $3874.5K |
| Topper James N | Director | 2025-09-08 | BUY | 1,260 | $24.99 | $31.5K |
| Kooij Louise Frederika | Chief Accounting Officer | 2025-09-03 | SELL | 18,073 | $25.09 | $453.5K |
| Kooij Louise Frederika | Chief Accounting Officer | 2025-08-25 | SELL | 8,269 | $24.86 | $205.6K |
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2025-08-22 | SELL | 100,000 | $24.72 | $2472K |
| Topper James N | Director | 2025-08-11 | BUY | 471 | $23.98 | $11.3K |
| Kling Douglas F | COO | 2025-07-16 | SELL | 98,612 | $21.26 | $2096.5K |
| Topper James N | Director | 2025-06-25 | BUY | 3,780 | $18.38 | $69.5K |
| Kling Douglas F | COO | 2025-06-16 | SELL | 100,000 | $19.29 | $1929K |
| Topper James N | Director | 2025-06-16 | BUY | 8,584 | $19.5 | $167.4K |
| Topper James N | Director | 2025-03-26 | BUY | 1,135 | $22.49 | $25.5K |
| Kooij Louise Frederika | Chief Accounting Officer | 2025-03-04 | SELL | 150,000 | $20.37 | $3055.5K |
| Topper James N | Director | 2025-03-04 | BUY | 4,005 | $21.02 | $84.2K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-30 | SELL | 29,846 | $25.54 | $762.3K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-27 | SELL | 74,910 | $25.98 | $1946.2K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-24 | SELL | 91,068 | $25.58 | $2329.5K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-19 | SELL | 157,234 | $25.86 | $4066.1K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-17 | SELL | 115,480 | $25.95 | $2996.7K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-13 | SELL | 191,762 | $25.34 | $4859.2K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-12-11 | SELL | 462,288 | $25.4 | $11742.1K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-11-18 | SELL | 41,803 | $25.07 | $1048K |
| Forbion Capital Fund IV Cooperatief U.A. | 10% Owner | 2024-11-14 | SELL | 10,898 | $25.01 | $272.6K |
| Kooij Louise Frederika | Chief Accounting Officer | 2024-10-01 | SELL | 45,000 | $15.72 | $707.4K |
| Audet Juliette Berangere | Chief Business Officer | 2024-09-26 | BUY | 1,104 | $15.7 | $17.3K |
| Davidson Michael H. | CEO | 2024-08-20 | BUY | 5,000 | $16.27 | $81.4K |
| Davidson Michael H. | CEO | 2024-06-20 | BUY | 5,000 | $17.26 | $86.3K |
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2024-03-26 | SELL | 190,476 | $21.5 | $4095.2K |
| Topper James N | Director | 2024-03-26 | BUY | 8,429 | $21.5 | $181.2K |
| LANGE LOUIS G | Director | 2024-02-13 | BUY | 5,000 | $19 | $95K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked